Immunotherapies against HER2-Positive Breast Cancer

SIMPLE SUMMARY: A wide range of treatments are available for HER2-positive breast cancer, which have greatly improved the prognosis and quality of life of these patients. However, resistance to HER2-targeted or untargeted therapies is common in clinical practice and is associated with metastasis, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Duro-Sánchez, Santiago, Alonso, Macarena Román, Arribas, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954045/
https://www.ncbi.nlm.nih.gov/pubmed/36831412
http://dx.doi.org/10.3390/cancers15041069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954045/
https://www.ncbi.nlm.nih.gov/pubmed/36831412
http://dx.doi.org/10.3390/cancers15041069

Ejemplares similares